NCT01505439View on ClinicalTrials.gov

A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence

PHASE4CompletedINTERVENTIONAL
Enrollment

311

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Stress Urinary IncontinenceUrgency Urinary Incontinence
Interventions
DRUG

solifenacin

oral

Trial Locations (6)

Unknown

Site KR00003, Daegu

SIte KR00004, Incheon

Site KR00001, Jeonam

Site KR00002, Jungnam

Site KR00005, Pusan

Site KR00006, Seoul

All Listed Sponsors
collaborator

Astellas Pharma Korea, Inc.

INDUSTRY

lead

Jeong Gu Lee

OTHER

NCT01505439 - A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence | Biotech Hunter | Biotech Hunter